1,329
Views
13
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Adherence to inhaled therapy in COPD: effects on survival and exacerbations

Pages 115-117 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Faustine Dalon, Gilles Devouassoux, Manon Belhassen, Gaëlle Nachbaur, Camille Correia Da Silva, Lynda Sail, Flore Jacoud, Christos Chouaid & Eric Van Ganse. (2019) Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2905-2915.
Read now
Andrea Arfè, Federica Nicotra, Isa Cerveri, Roberto de Marco, Adriano Vaghi, Luca Merlino & Giovanni Corrao. (2016) Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long-Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 13:5, pages 540-546.
Read now

Articles from other publishers (11)

Anan S. Jarab, Walid Al-Qerem, Karem H. Alzoubi, Shrouq Abu Heshmeh, Tareq L. Mukattash, Abdallah Y. Naser & Yazid N. Al Hamarneh. (2023) Health-related quality of life and its associated factors in patients with chronic obstructive pulmonary disease. PLOS ONE 18:10, pages e0293342.
Crossref
Armand-Gabriel Rajnoveanu, Ruxandra-Mioara Rajnoveanu, Nicoleta Stefania Motoc, Paraschiva Postolache, Gabriel Gusetu & Milena Adina Man. (2022) COPD in Firefighters: A Specific Event-Related Condition Rather than a Common Occupational Respiratory Disorder. Medicina 58:2, pages 239.
Crossref
Grzegorz Kardas, Michał Panek, Piotr Kuna & Przemysław Kardas. (2020) Primary non-adherence to inhaled medications measured with e-prescription data from Poland. Clinical and Translational Allergy 10:1.
Crossref
F. Dalon, E. Van Ganse, C. Correia Da Silva, G. Nachbaur, L. Saïl & M. Belhassen. (2019) Revue générale sur l’adhésion aux traitements inhalés de la BPCO. Revue des Maladies Respiratoires 36:7, pages 801-849.
Crossref
Magdalena Humenberger, Andreas Horner, Anna Labek, Bernhard Kaiser, Rupert Frechinger, Constanze Brock, Petra Lichtenberger & Bernd Lamprecht. (2018) Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulmonary Medicine 18:1.
Crossref
Jee-Ae Kim, Min Kyoung Lim, Kunil Kim, JuHee Park & Chin Kook Rhee. (2017) Adherence to Inhaled Medications and its Effect on Healthcare Utilization and Costs Among High-Grade Chronic Obstructive Pulmonary Disease Patients. Clinical Drug Investigation 38:4, pages 333-340.
Crossref
Nicolas RocheGerhard ScheuchJohn N. PritchardCornelia Nopitsch-MaiDeepika A. LakhaniBhawana SalujaJanine JamiesonAndrew DundonRoisin WallaceSusan HolmesDavid CipollaMyrna B. DolovichSamir A. ShahSvetlana Lyapustina. (2017) Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM Workshop. Journal of Aerosol Medicine and Pulmonary Drug Delivery 30:1, pages 1-13.
Crossref
Bruce G. Bender, Ramon A. Hernandez Vecino, Kevin McGrath & Spencer Jones. (2016) Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone Propionate Combination Therapy. The Journal of Allergy and Clinical Immunology: In Practice 4:5, pages 884-889.
Crossref
Onur Turan, Beyazit Yemez & Oya Itil. (2013) The effects of anxiety and depression symptoms on treatment adherence in COPD patients. Primary Health Care Research & Development 15:03, pages 244-251.
Crossref
Jamie Bryant, Vanessa M McDonald, Allison Boyes, Rob Sanson-Fisher, Christine Paul & Jessica Melville. (2013) Improving medication adherence in chronic obstructive pulmonary disease: a systematic review. Respiratory Research 14:1, pages 109.
Crossref
Maher R. Khdour, Ahmed F. Hawwa, Joseph C. Kidney, Bronagh M. Smyth & James C. McElnay. (2012) Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). European Journal of Clinical Pharmacology 68:10, pages 1365-1373.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.